The responses of plasma renin activity, plasma angiotensin II, plasma aldosterone, cortisol, and corticosterone to sodium deprivation and to angiotensin II infusion (100 ng/min) were measured in 8 normotensive patients and in 17 patients with essential hypertension. Following sodium deprivations, plasma renin activity rose from 0.513 ±0.100 to 1.029 ±0.124 ng/ml hour" 1 in normotensive patients and from 0.406 ± 0.077 to 0.629 ± 0.059 ng/ml hour-1 in hypertensive patients. Plasma angiotensin II did not parallel changes in plasma renin activity: in normotensive patients plasma angiotensin II was unchanged by sodium deprivation (31.8 ± 6 . 0 compared with 30.
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parallel those of plasma renin (10) (11) (12) . Finally, it has been suggested that the dissociation of plasma renin and plasma aldosterone might be explained by an enhanced adrenal sensitivity to circulating levels of plasma angiotensin II in hypertensive patients (4, 13, 14) . The current study was designed to elucidate these possibilities by the concurrent measurement of plasma renin, angiotensin II, and adrenal corticosteroids in nonnotensive and hypertensive patients during sodium deprivation and recumbency. Angiotensin II infusion was also performed to determine whether there were any gross changes in adrenal sensitivity to angiotensin in the two groups of patients or during sodium deprivation.
Methods
Seventeen hypertensive patients (11 male, 6 female), with a mean age of 43 years, were studied. Nine patients had never received drug treatment, and in the other 8 patients all medication was stopped at least 3 weeks before the study. None of the patients included in the study showed evidence of a renal or an endocrine cause for their hypertension in an investigation which included plasma and urinary electrolyte measurements, urinary catecholamine estimation, and intravenous pyelography in all cases and renal arteriography where indicated (9 patients).
Eight normotensive volunteers (6 male, 2 female), with a mean age of 46 years, were also studied. They were selected from a group of patients in the hospital because of orthopedic conditions and were all free from cardiovascular and renal disease. In all cases, the study was performed at least 3 weeks after any operative procedure. No patient was receiving treatment known to affect plasma renin levels or sodium metabolism such as progestational agents, diuretics, or sodium-containing drugs.
All subjects were hospital inpatients and, on the first day of the study, commenced a supplement of 100 mEq Na + /day as salt for 5 days in addition to a full diet. Also 24-hour collections of urine were commenced immediately and continued for 10 consecutive days. Plasma urea, sodium, and potassium were measured on each alternate day.
At 9 AM on the fifth day of the study, after 12 hours of recumbency, blood was withdrawn from the brachial artery, using local anesthesia; 20 ml of blood was collected in a chilled syringe containing 1.0 ml of 0.1M dimercaprol and 1.0 ml of 0 . 1 M ethylenediaminetetraaceric acid and CircuUtion Rtstarcb, Vol. XXXI, Novtmbtr 1972 stored on ice until centrifugation to separate the plasma for subsequent assay of angiotensin II and renin. An additional 20 ml of blood was collected in a tube containing heparin, and the separated plasma was used for determination of aldosterone, cortisol, and corticosterone.
A catheter was inserted into an antecubital vein, and angiotensin II (Hypertensin, Ciba), 1 /ig/ml in 5% dextrose, was infused at a constant rate of 0.1 ml/min for 2 hours with a Braun Unital infusion pump. Blood pressure was measured at 15-minute intervals with a sphygmomanometer. After 2 hours and before the infusion was stopped, arterial blood was again collected for determination of renin, angiotensin II, aldosterone, cortisol, and corticosterone.
The patients were then placed on a low-sodium diet containing 10 mEq Na + /day for 5 days. At 9 AM on the tenth day of the study, arterial blood samples were taken as before after 12 hours of recumbency, and the angiotensin infusion was repeated.
In each of the 24-hour specimens, urinary sodium and potassium were measured by flame photometry with a Technicon autoanalyzer. Plasma renin activity was determined by a competitive antibody-displacement technique employing radioimmunoassay of the generated angiotensin I (15, 16) , and arterial plasma angiotensin II was measured by the method of Boyd et al. (17) . Plasma aldosterone, cortisol, and corticosterone levels were measured by the method of double isotope-derivative dilution (18, 19) .
Results
All results are means ± SE. Individual results are presented in Table 1 and mean values in Table 2 . Statistical comparisons were made using Student's /-test or the paired t-test, where appropriate.
URINARY SODIUM EXCRETION
The urinary sodium excretion on the final day of sodium loading was 185.2 ± 20.6 mEq/24 hours for hypertensive patients and 191.7 ±20.9 mEq/24 hours for normotensive patients. After 5 days of sodium deprivation, the values had fallen to 22.7 ± 10 mEq/24 hours for hypertensive patients and 25.8 ± 7.5 mEq/24 hours for normotensive patients. The pattern of urinary sodium excretion showed no significant differences between hypertensive and normotensive patients ( Fig. 1 ). Urinary sodium excretion during 5 days of sodium loading followed by 5 days of sodium deprivation in nonnotensive and hypertensive patients.
Plasma sodium showed no significant differences between hypertensive and nonnotensive patients, being 140.4 ±0.5 mEq/liter and 140.2 ±1.1 mEq/liter, respectively, during sodium loading and 139.9 ± 0.6 mEq/liter and 138.2 ±0.9 mEq/liter, respectively, during deprivation. The differences between plasma sodium in the sodium-loaded and the sodiumdeprived states were not statistically significant in either group.
Plasma potassium was unaltered in the nonnotensive patients following sodium deprivation (3.95 ±0.11 mEq/liter during sodium loading and 3.98 ±0.19 mEq/liter during sodium deprivation), but it rose significantly in the hypertensive patients (3.99 ±0.11 mEq/liter during sodium loading and 4.34± 0.10 mEq/liter during sodium deprivation, P < 0.01).
PLASMA RENIN ACTIVITY
Plasma renin activity in the nonnotensive patients increased with sodium deprivation from 0.513 ±0.100 to 1.029 ±0.124 ng/ml hour" 1 (P<0.02). In the hypertensive patients, plasma renin activity was slightly lower during sodium loading (0.406 ±0.077 ng/ml Plasma A_ pg/m Naf Na| Naf Na \
FIGURE 2
Plasma renin activity (PRA) and plasma angiotensin II levels during sodium loading (Nat) and sodium deprivation (Nal) in normotensive and hypertensive patients. 1 ) and rose with sodium deprivation to 0.629 ±0.059 ng/ml hour 1 (P<0.05), a level significantly lower than the plasma renin activity in the normotensive patients after sodium deprivation (P<0.005) (Fig. 2) .
PLASMA ANGIOTENSIN II
In the normotensive patients, plasma angiotensin II was unchanged by sodium deprivation, being 31.8 ± 6.0 pg/ml during sodium loading and 30.1±4.6 pg/ml during sodium deprivation (Fig. 2) . In contrast, plasma angiotensin II levels rose significantly in the hypertensive patients from 22.2 ± 3.4 pg/ml during sodium loading to 36.4 ± 5.1 pg/ml during sodium deprivation (P < 0.05).
PLASMA ALDOSTERONE
In the normotensive patients ( Fig. 3) , plasma aldosterone rose from 5.8 ± 1-3 to 15.3 ±2.4 ng/100 ml (P<0.01) following sodium deprivation. Similar results were obtained in the hypertensive patients ( Fig. 4) , the corresponding values being 5.9 ± 1.4
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A . Plasma aldosterone (ALDO) and angiotensin II (All) levels before and after angiotensin II infusion during both high-and low-sodium intake in normotensive subiects. Plasma aldosterone (ALDO) and angiotensin II (All) levels before and after angiotensin 11 infusion during high-and low-sodium intake in hypertensive subjects.
ng/ 100 ml and ( P < 0.001).
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ANGIOTENSIN II INFUSION
The infusion of angiotensin II at 100 ng/min caused no subjective feelings and produced no change in blood pressure or pulse rate.
In the normotensive patients, the infusion led to an elevation of plasma angiotensin II levels from 31.8 ± 6.0 to 88.7 ±19.2 pg/ml during sodium loading and from 30.1 ±4.6 to 61.7 ±6.7 pg/ml during sodium deprivation (Fig. 3) . For the hypertensive patients corresponding levels were 22.2 ± 3.4 to 52.2 ± 9.7 pg/ml (sodium loading) and 36.4 ± 5.1 to 75.7± 12.0 pg/ml (sodium deprivation) ( Fig.  4) .
Plasma renin activity fell consistently during the infusion in both groups of patients during both sodium loading and sodium deprivation (Fig. 5 ). In the hypertensive patients, plasma renin activity fell from 0.406 ± 0.077 to 
EFFECT OF ANGIOTENSIN INFUSION ON PLASMA ALDOSTERONE
Following the angiotensin II infusion during sodium loading in normotensive patients plasma aldosterone rose from 5.8 ± 1.3 to 10.4 ±2.1 ng/100 ml ( P < 0.025) and during sodium deprivation from 15.3 ± 2.4 to 19.6 ±3.6 ng/100 ml (P<0.05). In the hypertensive patients, the levels were similar, being 5.9 ± 1.4 to 11.4 ± 2.7 ng/100 ml (NS) during sodium loading and 14.4 ± 1.6 to 22.2 ±2.6 ng/100 ml ( P < 0.005) during sodium deprivation.
As seen in Figure 6 , the increment in plasma aldosterone concentration during the angiotensin II infusion was similar in both hypertensive and normotensive patients and was unaffected by the dietary sodium intake.
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PLASMA CORTICOSTERONE
Plasma corticosterone was 0.69 ± 0.19 /i.g/100 ml in the normotensive patients during sodium loading and did not change with sodium deprivation (0.65 ±0.12 /ng/100 ml). However, following angiotensin infusion the levels fell ( Fig. 7) , being 0.26 + 0.03 ig/100 ml (P<0.05) during sodium loading and 0.17 ±0.02 /ig/100 ml during sodium deprivation (P < 0.005). Similarly, plasma corticosterone was unaffected by sodium deprivation in the hypertensive patients, the values being 0.52 ± 0.11 /Jig/100 ml during sodium loading and 0.53 ± 0.08 /Ag/100 ml during sodium deprivation. After the angiotensin infusion performed during sodium loading, plasma corticosterone fell to 0.25±0.05 ^tg/100 ml (P<0.05) and, following the angiotensin infusion during sodium deprivation, plasma corticosterone fell to 0.27 ±0.05 /Ag/100 ml (P<0.01) ( Fig.  7) .
PLASMA CORTISOL
Plasma cortisol was unaffected by sodium deprivation in both groups of patients. For the normotensive patients, the values were 19.1 ± 1.9 /u.g/100 ml during sodium loading and 18.0 ±1.6 /xg/100 ml during sodium Plasma corticosterone levels before (BASAL) and after angiotensin II (AH) infusion during both high-and low-sodium intake in normotensive and hypertensive patients.
deprivation. In the hypertensive patients, plasma cortisol was 13.5 ± 0.9 /u,g/100 ml during sodium loading and 12.6 ± 1.0 figl 100 ml during sodium deprivation. However, the levels of plasma cortisol were significantly lower in the hypertensive patients than they were in the normotensive patients during both high-and low-sodium intake (P < 0.01 in both instances).
Highly significant depressions of plasma cortisol followed the angiotensin infusion in both groups of patients on both the high-and the low-sodium diet (Fig. 8) . For the normotensive patients, plasma cortisol fell to 12.0 ±1.4 /ng/100 ml following the infusion during sodium loading ( P < 0.005) and to 7.9 ± 0.7 /xg/100 ml during sodium deprivation (P < 0.001). Corresponding values in the BASAL Plasma cortisol levels before (BASAL) and after angiotensin II (All) infusion during both high-and low-sodium intake in normotensive and hypertensive patients.
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hypertensive patients were 7.5 ± 0.9 (P<0.001) and 7 . 4 ± 0 . 7 /ig/ml ( P < 0 . 0 0 1 ) .
Discussion
The results of the present study confirmed previous observations that following dietary sodium deprivation hypertensive patients show a smaller rise in plasma renin activity than do nonnotensive subjects (1) (2) (3) (4) (5) (6) (7) . Although in the hypertensive group, plasma angiotensin II rose to a similar extent as did plasma renin activity, angiotensin II levels accompanying sodium deprivation did not parallel those of plasma renin activity in nonnotensive patients. In this latter group, plasma angiotensin II did not rise despite the fact that plasma renin activity doubled. Failure of plasma angiotensin II levels to rise with sodium deprivation in nonnotensive patients has been reported by other workers (11, 12) and may be explained by our previous observation (20) that the metabolic clearance rate of angiotensin II rises during sodium deprivation in nonnotensive subjects.
Plasma aldosterone levels were similar in the hypertensive and nonnotensive patients during sodium loading and rose to the same degree in both groups following sodium deprivation. Although the renin-angiotensin system has been regarded as the mediator of enhanced aldosterone secretion during sodium deprivation (21) , there are several lines of evidence that other factors may stimulate aldosterone secretion in this situation (22) . We have previously reported that during sodium deprivation hypertensive patients show a normal elevation of plasma aldosterone despite smaller rises in plasma renin (8) . It is clear from the present study that the rise in plasma aldosterone accompanying sodium deprivation is not necessarily accompanied by a corresponding change in either plasma renin or plasma angiotensin II. Furthermore, it can be seen (Figs. 3, 4 ) that sodium deprivation produces larger rises in plasma aldosterone than does subpressor angiotensin II infusion even though the latter is associated with a much larger rise in the plasma angiotensin II level. A similar relationship between angioten-CircuUtum Resemrcb, Vol. XXXI, November 1972 sin II and plasma aldosterone was observed by Boyd and Peart (23) during sodium deprivation and angiotensin infusion in a small group of normal subjects.
Although this finding might conflict with the idea that angiotensin II is the major mediator of the rise in aldosterone secretion occurring during sodium deprivation, it could still be possible that sodium deprivation may lead to a greater responsiveness of the adrenal zona glomerulosa, so that a given level of angiotensin II would lead to a greater output of aldosterone during sodium deprivation than during sodium loading. In the studies reported here, there were no significant differences between nonnotensive and hypertensive patients in the elevation of plasma aldosterone that followed the angiotensin II infusion during either sodium loading or sodium deprivation. Although the levels of plasma angiotensin II produced by the infusion were not the same in the four groups because of the differences in metabolic clearance rate mentioned above (20) , these data demonstrate that, in man, the sensitivity of the adrenal zona glomerulosa to a given dose of angiotensin II is not markedly enhanced by sodium deprivation or by the presence of essential hypertension. Altered adrenal responsiveness to angiotensin II cannot be invoked to explain the discrepancy between plasma angiotensin II and plasma aldosterone levels accompanying sodium deprivation in nonnotensive subjects.
Plasma potassium in the hypertensive patients showed a small, but statistically significant, rise following sodium deprivation. Since small changes in plasma potassium have been shown to cause direct stimulation of adrenal aldosterone secretion (24) , the possibility that potassium contributes to the rise in plasma aldosterone in this situation cannot be excluded.
Following the angiotensin II infusion at subpressor dose levels, plasma angiotensin concentrations were within the physiological range (10, 25) and plasma renin activity consistently fell. Angiotensin II has been shown to inhibit renin release in animals (26) (27) (28) and man (29) , but the levels used have usually caused elevations of blood pressure. This study demonstrated the potent inhibitory effect that angiotensin II has on renin release in man and suggested that this effect may be a physiologically important feedback loop in the short-term regulation of renin secretion. Furthermore, the magnitude of the inhibition was similar in hypertensive and normotensive patients, indicating that this mechanism is operating normally in hypertensive patients and thus cannot be the explanation for the blunted renin levels observed in these patients.
Sodium deprivation did not affect the levels of plasma cortisol or plasma corticosterone in either group of patients. However, following angiotensin II infusion, plasma levels of both of these corticosteroids were significantly depressed. The manner in which angiotensin exerts this effect is unclear, but similar results have been previously reported (30) . Whatever the mechanism of this phenomenon, it is clear that the pattern of adrenal corticosteroid secretion following sodium deprivation is quite different from that induced by the infusion of angiotensin.
It is concluded from these studies that subpressor infusions of angiotensin II exert a potent feedback inhibition on renin release in normotensive and hypertensive man and that adrenocortical sensitivity to angiotensin II is unaltered by sodium deprivation or by the presence of essential hypertension. Also there was a discrepancy in the changes in endogenous plasma angiotensin II and aldosterone levels accompanying dietary sodium deprivation. Angiotensin infusions which produced levels of plasma angiotensin II in excess of those occurring during sodium deprivation failed to induce rises in plasma aldosterone to the same degree as did sodium deprivation. Further, the pattern of adrenocortical steroid secretion produced by angiotensin II infusion was different from that induced by sodium deprivation. It thus appears unlikely that angiotensin II alone is the mediator of the enhanced aldosterone secretion seen during dietary sodium deprivation in man.
